The tumor microenvironment (TME) represents a highly complex system that encompasses cellular components (such as cancer cells, stromal cells, and immune cells) and non-cellular components (such as ...

A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel ...

A new study published in Cancer Cell reveals that blocking a key nutrient-scavenging process in pancreatic tumors reprograms the tumor microenvironment—reducing fibrosis, enhancing T cell infiltration ...

Researchers at Oregon Health & Science University’s Knight Cancer Institute have developed a machine-learning tool that uses ...

Dr. Zhen Zeng's “MANAscore” Expedites the Effectiveness of Immunotherapy, Potentially Increasing Patient Outcomes and ...

Researchers have identified how cancer cells exploit ordinary metabolic processes to manipulate immune cells, supporting ...

New research defines four different immunologic subtypes of recurrent ovarian cancers and describes how those subtypes are ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the pricing of an ...

Blocking a key metabolic enzyme helps B cells fight liver tumors, revealing a new immunotherapy pathway for fatty liver–driven cancer in mice.

The remainder of 2025 will be busy for Vir Biotechnology as it strives to successfully pivot to developing cancer and infectious disease therapies.

HPVTIMER is a comprehensive web-based analysis tool based on the GEO database for HPV-associated cancers. HPVTIMER has four embedded analysis modules: Differential expression analysis module, ...

Several studies have now demonstrated that trained immunity occurs in the airways to several pathogens and products, while its utility is yet to be determined.